Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Nano Antibodies market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Nano Antibodiesmarket, defines the market attractiveness level of Nano Antibodies market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Nano Antibodies industry, describes the types of Nano Antibodies market, the applications of major players and the market size, and deeply analyzes the current situation of the global Nano Antibodies market and the development prospects and opportunities of Nano Antibodies industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Nano Antibodies market in Chapter 13.
By Player:
Ablynx
Alphamab
PREGENE
PersonGen
By Type:
Monovalent Nanobody
Multivalent and multispecific Nanobodies
Fusion Nanobody
By End-User:
Disease detection in vitro
Non-invasive diagnosis in vivo
Tumor targeted therapy
Nervous system disease
Circulatory disease
Infectious disease
Other
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Nano Antibodies Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Nano Antibodies Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Nano Antibodies Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Nano Antibodies Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Nano Antibodies Market Analysis and Outlook to 2022
-
7.1 Global Nano Antibodies Consumption (2017-2022)
-
7.2 United States Nano Antibodies Consumption (2017-2022)
-
7.3 Europe Nano Antibodies Consumption (2017-2022)
-
7.4 China Nano Antibodies Consumption (2017-2022)
-
7.5 Japan Nano Antibodies Consumption (2017-2022)
-
7.6 India Nano Antibodies Consumption (2017-2022)
-
7.7 South Korea Nano Antibodies Consumption (2017-2022)
8 Region and Country-wise Nano Antibodies Market Analysis and Outlook to 2028
-
8.1 Global Nano Antibodies Consumption Forecast (2022-2028)
-
8.2 United States Nano Antibodies Consumption Forecast (2022-2028)
-
8.3 Europe Nano Antibodies Consumption Forecast (2022-2028)
-
8.4 China Nano Antibodies Consumption Forecast (2022-2028)
-
8.5 Japan Nano Antibodies Consumption Forecast (2022-2028)
-
8.6 India Nano Antibodies Consumption Forecast (2022-2028)
-
8.7 South Korea Nano Antibodies Consumption Forecast (2022-2028)
9 Global Nano Antibodies Market Outlook by Types and Applications to 2022
-
9.1 Global Nano Antibodies Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Monovalent Nanobody Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Multivalent and multispecific Nanobodies Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Fusion Nanobody Consumption and Growth Rate (2017-2022)
-
9.2 Global Nano Antibodies Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Disease detection in vitro Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Non-invasive diagnosis in vivo Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Tumor targeted therapy Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Nervous system disease Consumption and Growth Rate (2017-2022)
-
9.2.5 Global Circulatory disease Consumption and Growth Rate (2017-2022)
-
9.2.6 Global Infectious disease Consumption and Growth Rate (2017-2022)
-
9.2.7 Global Other Consumption and Growth Rate (2017-2022)
10 Global Nano Antibodies Market Outlook by Types and Applications to 2028
-
10.1 Global Nano Antibodies Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Monovalent Nanobody Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Multivalent and multispecific Nanobodies Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Fusion Nanobody Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Nano Antibodies Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Disease detection in vitro Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Non-invasive diagnosis in vivo Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Tumor targeted therapy Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Nervous system disease Consumption Forecast and Growth Rate (2022-2028)
-
10.2.5 Global Circulatory disease Consumption Forecast and Growth Rate (2022-2028)
-
10.2.6 Global Infectious disease Consumption Forecast and Growth Rate (2022-2028)
-
10.2.7 Global Other Consumption Forecast and Growth Rate (2022-2028)
11 Global Nano Antibodies Import and Export Analysis (Top 5 Countries)
-
11.1 Global Nano Antibodies Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Nano Antibodies Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Nano Antibodies Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Nano Antibodies Market Competitive Analysis
-
14.1 Ablynx
-
14.1.1 Ablynx Company Details
-
14.1.2 Ablynx Nano Antibodies Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Ablynx Nano Antibodies Product and Service
-
14.2 Alphamab
-
14.2.1 Alphamab Company Details
-
14.2.2 Alphamab Nano Antibodies Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Alphamab Nano Antibodies Product and Service
-
14.3 PREGENE
-
14.3.1 PREGENE Company Details
-
14.3.2 PREGENE Nano Antibodies Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 PREGENE Nano Antibodies Product and Service
-
14.4 PersonGen
-
14.4.1 PersonGen Company Details
-
14.4.2 PersonGen Nano Antibodies Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 PersonGen Nano Antibodies Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Nano Antibodies
-
Figure Nano Antibodies Picture
-
Table Global Nano Antibodies Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Nano Antibodies Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Nano Antibodies Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Nano Antibodies Consumption by Country (2017-2022)
-
Figure United States Nano Antibodies Consumption and Growth Rate (2017-2022)
-
Table Europe Nano Antibodies Consumption and Growth Rate (2017-2022)
-
Figure China Nano Antibodies Consumption and Growth Rate (2017-2022)
-
Figure Japan Nano Antibodies Consumption and Growth Rate (2017-2022)
-
Figure India Nano Antibodies Consumption and Growth Rate (2017-2022)
-
Figure South Korea Nano Antibodies Consumption and Growth Rate (2017-2022)
-
Figure Global Nano Antibodies Consumption Forecast by Country (2022-2028)
-
Figure United States Nano Antibodies Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Nano Antibodies Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Nano Antibodies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Nano Antibodies Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Nano Antibodies Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Nano Antibodies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Monovalent Nanobody Consumption and Growth Rate (2017-2022)
-
Figure Global Multivalent and multispecific Nanobodies Consumption and Growth Rate (2017-2022)
-
Figure Global Fusion Nanobody Consumption and Growth Rate (2017-2022)
-
Figure Global Disease detection in vitro Consumption and Growth Rate (2017-2022)
-
Figure Global Non-invasive diagnosis in vivo Consumption and Growth Rate (2017-2022)
-
Figure Global Tumor targeted therapy Consumption and Growth Rate (2017-2022)
-
Figure Global Nervous system disease Consumption and Growth Rate (2017-2022)
-
Figure Global Circulatory disease Consumption and Growth Rate (2017-2022)
-
Figure Global Infectious disease Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Monovalent Nanobody Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Multivalent and multispecific Nanobodies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Fusion Nanobody Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Disease detection in vitro Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Non-invasive diagnosis in vivo Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Tumor targeted therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Nervous system disease Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Circulatory disease Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Infectious disease Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Nano Antibodies Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Nano Antibodies Export by Region (Top 5 Countries) (2017-2028)
-
Table Ablynx (Foundation Year, Company Profile and etc.)
-
Table Ablynx Nano Antibodies Sales, Price, Value and Gross Profit (2017-2022)
-
Table Ablynx Nano Antibodies Product and Service
-
Table Alphamab (Foundation Year, Company Profile and etc.)
-
Table Alphamab Nano Antibodies Sales, Price, Value and Gross Profit (2017-2022)
-
Table Alphamab Nano Antibodies Product and Service
-
Table PREGENE (Foundation Year, Company Profile and etc.)
-
Table PREGENE Nano Antibodies Sales, Price, Value and Gross Profit (2017-2022)
-
Table PREGENE Nano Antibodies Product and Service
-
Table PersonGen (Foundation Year, Company Profile and etc.)
-
Table PersonGen Nano Antibodies Sales, Price, Value and Gross Profit (2017-2022)
-
Table PersonGen Nano Antibodies Product and Service
-
